U.S. Professional Services Stock News

Why ASP Isotopes (ASPI) Is Drawing Attention After Its Latest Earnings ASP Isotopes (ASPI) is back on investors’ radar after its full year 2025 earnings report, which paired US$23.85 million of revenue with a net loss of US$175.09 million, along with a follow up business update call. See our latest analysis for ASP Isotopes. The share price now sits at US$5.00, with a 7 day share price return of 22.85% contrasting with a 90 day share price return decline of 29.48%. The 3 year total...

In early April 2026, iQIYI announced plans for iQIYI LAND in Wuhan’s Hanyangzao Cultural and Creative Industry Park, its first urban renewal–integrated theme park and fourth immersive IP-based park nationwide, while also launching Nadou Pro, an AI agent designed to support end-to-end professional film and TV production workflows. Together, the Wuhan park development and Nadou Pro launch underline how iQIYI is extending its content IP beyond streaming, into both offline experiential venues...

If you are wondering whether Star Bulk Carriers is priced attractively or already reflects its potential, this article breaks down what the current share price could mean for you as an investor. At a last close of US$24.73, the stock has returns of 2.6% over 7 days, 13.2% over 30 days, 27.7% year to date and 78.8% over 1 year. These recent moves are front of mind when thinking about value and risk. Recent coverage has focused on Star Bulk Carriers within the broader shipping sector,...

A law firm has launched an investigation and class action complaint targeting e.l.f. Beauty (NYSE:ELF) and its board of directors. The complaint alleges false and misleading statements related to revenue reporting and inventory disclosures. The case raises questions about the company’s financial reporting practices and board oversight. For investors tracking NYSE:ELF, this legal action comes at a time when the stock trades around $65.62, with a mixed return profile. Shares are up 3.8% over...

A10 Networks has recently reported its fourth quarter and full year 2024 results, showing modest revenue growth and highlighting progress across both service provider and enterprise customers. The company is leaning into new security and AI-focused offerings, including bot protection, DDoS mitigation, and solutions tailored for GPU-based AI infrastructure, which management positions as key future growth drivers. We’ll now examine how these emerging AI and security product initiatives may...

If you are wondering whether Enovis is priced attractively right now, the recent share performance and valuation checks offer some clear signals to unpack. The stock last closed at US$24.86, with returns of 9.2% over 7 days and 8.1% over 30 days, while year to date it is down 6.2%, and the 1 year return sits at a 23.1% decline, extending a 55.3% decline over 3 years and 67.8% over 5 years. These moves sit against a backdrop where investors have been reassessing Enovis within the Medical...

Citigroup (NYSE:C) reported its strongest quarterly results in a decade in Q1 2026, with net income up 42% year over year. The bank delivered record revenue in its markets segment, supported by double digit gains in both trading and investment banking. Wealth management revenue also showed significant growth, contributing to overall earnings strength. Citigroup reported substantial progress on its transformation plan, including asset divestitures and share repurchases. For investors...

Wondering if AAR is still reasonably priced after a strong run, or if you might be arriving late to the story? This article walks through what the current share price could mean for you. At a last close of US$123.77, AAR has returns of 8.6% over 7 days, 21.5% over 30 days, 46.6% year to date, 128.3% over 1 year, 127.8% over 3 years and 211.1% over 5 years. This naturally raises questions about what is already reflected in the price. The recent moves sit against a backdrop of ongoing interest...

Viatris (NasdaqGS:VTRS) is presenting four Phase 3 ophthalmic clinical study abstracts at the 2026 ASCRS Annual Meeting. The data include new findings in presbyopia and visual disturbance treatments using phentolamine ophthalmic solutions. These late stage results may be important for Viatris' ophthalmology portfolio and potential future product approvals. For investors tracking NasdaqGS:VTRS at a share price of $13.83, this spotlight on Phase 3 ophthalmic data comes on top of a share price...

In early April 2026, Alnylam Pharmaceuticals highlighted new clinical data for its ATTR-CM therapy vutrisiran at the American College of Cardiology meeting, while also marking free cash flow breakeven in 2025 and continued recognition for its RNAi-based cardiovascular portfolio. Investor interest was further underlined as a large-cap growth fund added Alnylam to its portfolio, aligning institutional conviction with improving financial footing and reinforcing attention on the company’s...

NextDecade Corporation recently announced it will host a conference call and webcast on May 1, 2026, to review its first-quarter 2026 developments, accompanied by a press release and presentation on its website. This update comes as the company’s liquefied natural gas and carbon capture ambitions intersect with weaker sector sentiment following a US-Iran ceasefire that pressured natural gas prices. Against this backdrop, we will examine how shifting energy-sector sentiment tied to the...

Wondering whether Silgan Holdings at around US$41.87 is priced for opportunity or caution? This article breaks down what the current share price could be implying about value. The stock is up 6.1% over the last 7 days and 0.6% over the past month, yet year to date it is only up 1.5%, and the 1 year return sits at a 14.0% decline. That mix of recent gains and a weaker 1 year and 3 year record, with returns of a 14.0% decline and 16.2% decline respectively, has kept Silgan on the radar for...

If you are wondering whether AllianceBernstein Holding at around US$38.67 is still fairly priced or starting to look interesting, you are not alone. The stock's recent returns, including 1.4% over the past week, 1.5% over the past month, 0.1% year to date, 11.3% over the past year, 36.5% over three years, and 47.0% over five years, provide a useful backdrop for thinking about value and risk today. Recent coverage has focused on AllianceBernstein Holding's role in the capital markets sector...

Wondering if Oceaneering International at around US$37.43 is offering fair value or if the market is getting ahead of itself? This article walks you through the key signals that can help you answer that question. The stock has delivered returns of 2.3% over the last 7 days, 12.5% over 30 days, 50.6% year to date and 120.4% over the past year, with 3 year and 5 year returns of 105.8% and 245.6% respectively. This naturally raises questions about what is already priced in. Recent attention on...

Wondering if ImmunityBio at around US$7.30 is still priced for opportunity or already reflecting the story most investors see? This article is built to help you frame that question clearly. The stock has delivered a 261.4% return year to date and 162.6% over the past year. However, the last 30 days show a 13.0% decline and the last week a 6.4% gain, which can change how you think about both potential and risk. Recent coverage of ImmunityBio has focused on how its clinical pipeline and...

CleanSpark (CLSK) has drawn fresh investor attention after reporting unaudited March 2026 bitcoin production of 658 coins, alongside an operational hashrate of 50.0 EH/s and ongoing commentary from research firms on its mining and infrastructure footprint. See our latest analysis for CleanSpark. The latest bitcoin production figures and analyst commentary sit alongside a 1 day share price return of 7.39% and a 7 day share price return of 18.24%. The 90 day share price return shows a 14.26%...

Amentum Holdings (NYSE:AMTM) played an essential role in NASA's Artemis II mission, the first crewed launch of the Artemis program. The company supported ground systems operations, critical launch support, safety systems deployment, and post mission recovery of the Orion spacecraft. This work contributes to NASA's goal of a sustained lunar presence and future deep space missions. Amentum operates as a mission critical engineering and operations partner to US government agencies and other...

If you are wondering whether Teradata at US$26.02 is priced attractively or already reflects the story you are buying into, this article walks through what the market might be saying about value. The share price is up 26.9% over the past year, even though the year to date move sits at a 12.4% decline. This can change how you think about both upside and risk. Recent coverage has focused on Teradata's role in data and analytics software and how the company is positioned in a competitive...

Byrna Technologies Inc. has reported past first‑quarter 2026 results showing sales rising to US$29.05 million while net income fell to US$0.80 million, reducing earnings per share versus the prior year. The new CEO outlined a push toward brick‑and‑mortar and dealer growth amid weaker ecommerce conversion, as analysts adjusted their views on the company’s prospects. Now we’ll explore how weaker online conversion but growing retail channels may reshape Byrna’s existing investment narrative and...

FedEx announced that CFO John Dietrich will step down from his role concurrent with the completion of the planned FedEx Freight spinoff. Claude Russ has been appointed interim CFO, taking over financial leadership during the separation of FedEx Freight into an independent public company. The transition aligns with a broader organizational reshaping as FedEx adjusts its structure around distinct business units. For investors watching NYSE:FDX, this leadership change comes at a time when the...

What Leggett & Platt’s recent share performance signals for investors Leggett & Platt (LEG) has caught investors’ attention after a recent rebound, with the stock up about 15% over the past week and roughly 10% over the past month, following a mixed longer term track record. See our latest analysis for Leggett & Platt. While the recent 12.61% 1 day and 15.27% 7 day share price returns suggest momentum is picking up again, this sits against a weaker multi year picture, reflected in the 60.50%...

Over the last 7 days, the United States market has risen by 4.2%, contributing to a 29% increase over the past year, with earnings forecasted to grow by 16% annually. In this environment of growth, identifying stocks that may be trading below their estimated value can offer investors potential opportunities for capitalizing on future gains.

Over the last 7 days, the United States market has risen by 4.2%, contributing to a significant 29% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with substantial insider ownership can be particularly appealing as they often signify strong confidence from those closely involved in their operations.

The market has shown impressive growth, with a 4.2% increase over the last week and a 29% rise over the past year, while earnings are projected to grow by 16% annually. Although the term 'penny stock' may seem outdated, it still represents an area of investment that can uncover significant opportunities in smaller or newer companies. By focusing on those with strong financials and clear growth potential, investors can find hidden value in quality penny stocks that offer both stability and...